289 related articles for article (PubMed ID: 24338958)
1. Absence of a role for interleukin-13 in inflammatory bowel disease.
Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
[TBL] [Abstract][Full Text] [Related]
2. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
3. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases.
Serriari NE; Eoche M; Lamotte L; Lion J; Fumery M; Marcelo P; Chatelain D; Barre A; Nguyen-Khac E; Lantz O; Dupas JL; Treiner E
Clin Exp Immunol; 2014 May; 176(2):266-74. PubMed ID: 24450998
[TBL] [Abstract][Full Text] [Related]
4. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
[TBL] [Abstract][Full Text] [Related]
5. Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients.
Candia E; Díaz-Jiménez D; Langjahr P; Núñez LE; de la Fuente M; Farfán N; López-Kostner F; Abedrapo M; Alvarez-Lobos M; Pinedo G; Beltrán CJ; González C; González MJ; Quera R; Hermoso MA
Immunobiology; 2012 Jun; 217(6):634-42. PubMed ID: 22101184
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.
Camoglio L; Te Velde AA; Tigges AJ; Das PK; Van Deventer SJ
Inflamm Bowel Dis; 1998 Nov; 4(4):285-90. PubMed ID: 9836081
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 production in inflammatory bowel disease: differing production patterns in Crohn's disease and ulcerative colitis.
Del Zotto B; Mumolo G; Pronio AM; Montesani C; Tersigni R; Boirivant M
Clin Exp Immunol; 2003 Oct; 134(1):120-6. PubMed ID: 12974764
[TBL] [Abstract][Full Text] [Related]
8. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
9. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
[TBL] [Abstract][Full Text] [Related]
10. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
Van Damme N; De Keyser F; Demetter P; Baeten D; Mielants H; Verbruggen G; Cuvelier C; Veys EM; De Vos M
Clin Exp Immunol; 2001 Sep; 125(3):383-90. PubMed ID: 11531945
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.
Gurbindo C; Sabbah S; Menezes J; Justinich C; Marchand R; Seidman EG
J Pediatr Gastroenterol Nutr; 1993 Oct; 17(3):247-54. PubMed ID: 8271122
[TBL] [Abstract][Full Text] [Related]
12. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease.
Ludwiczek O; Vannier E; Borggraefe I; Kaser A; Siegmund B; Dinarello CA; Tilg H
Clin Exp Immunol; 2004 Nov; 138(2):323-9. PubMed ID: 15498044
[TBL] [Abstract][Full Text] [Related]
14. Lamina propria mononuclear cells express and respond to interleukin-2 differently in Crohn's disease and ulcerative colitis.
Shinoda M; Haruta J; Tanimoto M; Ando T; Hosokawa T; Ina K; Kusugami K
Intern Med; 1996 Sep; 35(9):679-85. PubMed ID: 8915691
[TBL] [Abstract][Full Text] [Related]
15. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
16. Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.
Takayama T; Kamada N; Chinen H; Okamoto S; Kitazume MT; Chang J; Matuzaki Y; Suzuki S; Sugita A; Koganei K; Hisamatsu T; Kanai T; Hibi T
Gastroenterology; 2010 Sep; 139(3):882-92, 892.e1-3. PubMed ID: 20638936
[TBL] [Abstract][Full Text] [Related]
17. IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis.
Fuss IJ; Joshi B; Yang Z; Degheidy H; Fichtner-Feigl S; de Souza H; Rieder F; Scaldaferri F; Schirbel A; Scarpa M; West G; Yi C; Xu L; Leland P; Yao M; Mannon P; Puri RK; Fiocchi C; Strober W
Gut; 2014 Nov; 63(11):1728-36. PubMed ID: 24515806
[TBL] [Abstract][Full Text] [Related]
18. Bioactive IL-18 expression is up-regulated in Crohn's disease.
Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
[TBL] [Abstract][Full Text] [Related]
19. NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis.
Ranson N; Veldhuis M; Mitchell B; Fanning S; Cook AL; Kunde D; Eri R
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583612
[TBL] [Abstract][Full Text] [Related]
20. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
Kusugami K; Youngman KR; West GA; Fiocchi C
Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
